Spots Global Cancer Trial Database for met activating mutation
Every month we try and update this database with for met activating mutation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Crizotinib for ROS1 and MET Activated Lung Cancer | NCT04084717 | Non-squamous No... Stage IV Non-sm... ROS1 Gene Rearr... MET Activating ... MET Amplificati... | Crizotinib | 18 Years - | University Health Network, Toronto |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
